(GRAY) – Company Press Releases
-
CalciMedica Announces Private Placement of up to Approximately $55 Million
-
CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition
-
CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
-
CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition
-
CalciMedica Announces Upcoming Presentations and Events in September
-
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023
-
CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP)
-
CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
-
Graybug Announces Name and Trading Symbol Change
-
Graybug Announces Name and Trading Symbol Change
-
Graybug and CalciMedica Enter into Definitive Merger Agreement
-
Graybug and CalciMedica Enter into Definitive Merger Agreement
-
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
-
Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022
-
Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments
-
Graybug Vision Reports Financial Results for the Three and Six Months Ended June 30, 2022, and Recent Corporate Developments
-
Graybug to Present at the 2022 OIS Retina Innovation Summit
-
Graybug to Present at the 2022 OIS Retina Innovation Summit
-
Graybug Announces Review of Strategic Alternatives
-
Graybug Announces Review of Strategic Alternatives
-
Graybug to Present Clinical Development Plan Update for GB-102 at the 2022 Clinical Trials at the Summit Meeting
-
Graybug to Present Clinical Development Plan Update for GB-102 at the 2022 Clinical Trials at the Summit Meeting
-
Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments
-
Graybug Vision Reports First Quarter 2022 Financial Results and Recent Corporate Developments
-
Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting
-
Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meeting
-
Graybug to Present at the 2022 ASCRS Annual Meeting
-
Graybug to Present at the 2022 ASCRS Annual Meeting
-
Graybug Vision Appoints Dirk Sauer to Board of Directors
-
Graybug Vision Appoints Dirk Sauer to Board of Directors
-
Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023
-
Graybug Announces Pipeline Expansion, Current Cash Expected to Deliver Three Clinical Readouts in 2023
-
Graybug Vision to Host Virtual R&D Day on March 30, 2022
-
Graybug Vision to Host Virtual R&D Day on March 30, 2022
-
Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments
-
Graybug Vision Reports Full Year 2021 Financial Results and Recent Corporate Developments
-
Graybug to Participate in Three Upcoming Medical and Investor Conferences
-
Graybug to Participate in Three Upcoming Medical and Investor Conferences
-
Graybug Vision Makes Key Hires to Further Build Momentum Behind its Pipeline
-
Graybug Vision Makes Key Hires to Further Build Momentum Behind its Pipeline
-
Metals & Mining Investor Presentations Now Available for On-Demand Viewing
-
Metals & Mining Live Virtual Investor Conference December 8th & 9th
-
Graycliff Exploration to Webcast Live at VirtualInvestorConferences.com on December 9th
-
Graybug Vision to Participate in the Piper Sandler 33rdĀ Annual Virtual Healthcare Conference
-
Graybug Vision to Participate in the Piper Sandler 33rdĀ Annual Virtual Healthcare Conference
-
Graybug Vision Announces Financial Results for the Three and Nine Months Ended September 30, 2021, and Recent Corporate Developments
-
Graybug Vision Announces Financial Results for the Three and Nine Months Ended September 30, 2021, and Recent Corporate Developments
-
Graybug Vision to Participate in the American Academy of Ophthalmology 2021 Annual Meeting
-
Graybug Vision to Participate in the American Academy of Ophthalmology 2021 Annual Meeting
-
Graybug Vision to Participate in the Annual Ophthalmology Innovation Summit (OIS) Retina@ASRS Conference
Back to GRAY Stock Lookup